Navicare Biotech Co., Ltd. (TPEX:8472)
74.20
-4.00 (-5.12%)
Sep 8, 2026, 1:30 PM CST
| Market Cap | 1.32B -8.1% |
| Revenue (ttm) | 505.82M +29.3% |
| Net Income | -11.41M |
| EPS | -0.64 |
| Shares Out | 17.74M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 37,101 |
| Open | 82.40 |
| Previous Close | 78.20 |
| Day's Range | 73.00 - 82.40 |
| 52-Week Range | 55.00 - 99.00 |
| Beta | -0.16 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |